Nā Huahana a me nā Hoʻonā a Macro & Micro-Test

PCR Fluorescence | Hoʻonui Isothermal | Chromatography Colloidal Gold | Immunochromatography Fluorescence

Nā huahana

  • ʻO ke gene A/B toxin Clostridium difficile(C.diff)

    ʻO ke gene A/B toxin Clostridium difficile(C.diff)

    Ua manaʻo ʻia kēia pahu hana no ka ʻike qualitative in vitro o ka gene clostridium difficile toxin A a me ka gene toxin B i loko o nā hāpana ʻōpala mai nā poʻe maʻi me ka maʻi clostridium difficile i manaʻo ʻia.

  • ʻO Clostridium Difficile Glutamate Dehydrogenase (GDH) a me ka Toxin A/B

    ʻO Clostridium Difficile Glutamate Dehydrogenase (GDH) a me ka Toxin A/B

    Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana i ka Glutamate Dehydrogenase (GDH) a me Toxin A/B in vitro i loko o nā hāpana ʻōpala o nā hihia clostridium difficile i manaʻo ʻia.

  • ʻO ke kāpapenemase

    ʻO ke kāpapenemase

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative o NDM, KPC, OXA-48, IMP a me VIM carbapenemases i hana ʻia i loko o nā hāpana bacteria i loaʻa ma hope o ka moʻomeheu in vitro.

  • ʻO ke Gene Kū'ē Carbapenem (KPC/NDM/OXA 48/OXA 23/VIM/IMP)

    ʻO ke Gene Kū'ē Carbapenem (KPC/NDM/OXA 48/OXA 23/VIM/IMP)

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i nā genes kūʻē carbapenem i loko o nā laʻana sputum kanaka, nā laʻana swab rectal a i ʻole nā ​​kolone maʻemaʻe, me KPC (Klebsiella pneumonia carbapenemase), NDM (New Delhi metallo-β-lactamase 1), OXA48 (oxacillinase 48), OXA23 (oxacillinase 23), VIM (Verona Imipenemase), a me IMP (Imipenemase).

  • ʻO ka maʻi Influenza A Universal/H1/H3

    ʻO ka maʻi Influenza A Universal/H1/H3

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka maʻi influenza A universal type, H1 type a me H3 type nucleic acid i nā laʻana swab nasopharyngeal kanaka.

  • Ka maʻi Ebola o Zaire

    Ka maʻi Ebola o Zaire

    He kūpono kēia pahu hana no ka ʻike qualitative o ka Zaire Ebola virus nucleic acid i loko o nā laʻana serum a plasma paha o nā maʻi i manaʻo ʻia he maʻi Zaire Ebola (ZEBOV).

  • ʻO Adenovirus Universal

    ʻO Adenovirus Universal

    Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o ka adenovirus nucleic acid i loko o ka nasopharyngeal swab a me ka ʻāʻī swab laʻana.

  • 4 ʻAno o nā maʻi hanu

    4 ʻAno o nā maʻi hanu

    Hoʻohana ʻia kēia kime no ka ʻike ʻana i ka qualitative o2019-nCoV, ka maʻi influenza A, ka maʻi influenza B a me ka maʻi respiratory syncytial nucleic acidsi loko o ke kanakaonā hāpana swab ropharyngeal.

  • 12 ʻAno o ka maʻi hanu

    12 ʻAno o ka maʻi hanu

    Hoʻohana ʻia kēia kit no ka hui ʻana o ka qualitative detection o SARS-CoV-2, influenza A virus, influenza B virus, adenovirus, mycoplasma pneumoniae, rhinovirus, respiratory syncytial virus a me parainfluenza virus (Ⅰ, II, III, IV) a me metapneumovirus kanaka i loko o nā swabs oropharyngeal..

  • Ka maʻi Hepatitis E

    Ka maʻi Hepatitis E

    He kūpono kēia pahu hana no ka ʻike qualitative o ka maʻi hepatitis E (HEV) nucleic acid i loko o nā laʻana serum a me nā laʻana ʻōpala in vitro.

  • Ka maʻi Hepatitis A

    Ka maʻi Hepatitis A

    He kūpono kēia pahu hana no ka ʻike ʻana i ka waikawa nucleic o ka maʻi hepatitis A (HAV) i loko o nā laʻana serum a me nā laʻana ʻōpala in vitro.

  • ʻO ka fluorescence helu DNA o ka maʻi Hepatitis B

    ʻO ka fluorescence helu DNA o ka maʻi Hepatitis B

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka nui o ka waikawa nucleic o ka maʻi hepatitis B i loko o nā laʻana serum kanaka a i ʻole plasma.